Triggers include genetic susceptibility (HLA-DR3/DR4) and environmental factors (viral infections, gut microbiome alterations)
Clinical implications
BPC-157 is generally described with more frequent administration, while TB-500 is often described with a higher initial "loading" frequency followed by a lower maintenance frequency
Those numbers buy you a licensed medical provider, a 503A compounding pharmacy supply chain, individualized dosing, in-person injection training, and follow-up at the clinic
CagriSemas performance fell short of Novos prior projections for its drug combo, however, and investors were not impressed
Cagrilintide is a long-acting amylin analogue administered once weekly by subcutaneous injection, reducing appetite by slowing gastric emptying and suppressing glucagon